4893 items matching your search terms.

Fibroblast growth factor 21 and cardiovascular outcome events in the fenofi brate intervention and event lowering in diabetes (FIELD) study

Ong, KL Januszewski, AS O'Connell, R Jenkins, AJ Xu, A Sullivan, DR Barter, PJ Hung, WT Keech, AC Rye, KA

The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study

Ong, K. L. Januszewski, A. S. O’Connell, R. Jenkins, A. J. Xu, A. Sullivan, D. R. Barter, P. J. Hung, W. T. Scott, R. S. Taskinen, M. R. Keech, A. C. Rye, K. A.
DIABETOLOGIA, 2014     DOI:10.1007/s00125-014-3458-7

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

Pagani, O. Regan, M. M. Walley, B. A. Fleming, G. F. Colleoni, M. Lang, I. Gomez, H. L. Tondini, C. Burstein, H. J. Perez, E. A. Ciruelos, E. Stearns, V. Bonnefoi, H. R. Martino, S. Geyer, C. E., Jr. Pinotti, G. Puglisi, F. Crivellari, D. Ruhstaller, T. Winer, E. P. Rabaglio-Poretti, M. Maibach, R. Ruepp, B. Giobbie-Hurder, A. Price, K. N. Bernhard, J. Luo, W. Ribi, K. Viale, G. Coates, A. S. Gelber, R. D. Goldhirsch, A. Francis, P. A. Text, Soft Investigators International Breast Cancer Study, Group
NEW ENGLAND JOURNAL OF MEDICINE, 2014     DOI:10.1056/NEJMoa1404037

Left-sided breast cancer locoregional radiation therapy with deep inspiration breath hold: does volumetric modulated arc therapy reduce the cardiac dose further when compared to tangential intensity modulated radiation therapy?

Pham, T. T. Ward, R. Latty, D. Owen, C. Sykes, J. Gebski, V. Tiver, K. Stuart, K. Ahern, V. Wang, W.

Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients

Phu, A. Xu, Z. Brakoulias, V. Mahant, N. Fung, V.S.C. Moore, G.D. Martin, A. Starcevic, V. Krause, M.
JOURNAL OF CLINICAL NEUROSCIENCE, 2014     DOI:10.1016/j.jocn.2013.02.032

Disseminating results from academic and investigator-initiated trials

Pike, R

Correlation of PI3KCA and extended RAS gene mutation status with outcomes from the phase III AGITG MAX involving capecitabine alone or in combination with bevacizumab with or without mitomycin C in advanced colorectal cancer

Price, TJ Bruhn, MA Lee, C Hardingham, JE Townsend, AR Mann, K Simes, J Weickhardt, A Wrin, JW Wilson, K Gebski, V Van Hazel, G Robinson, B Cunningham, D Tebbutt, NC

Molecular subgroups from the AGITG MAX trial; right or left primary site of colorectal cancer and outcomes for metastatic colorectal cancer

Price, TJ Buizen, L Hardingham, J Lee, CK Townsend, A Bruhn, M Simes, RJ Wilson, K Gebski, V Tebbutt, NC
, 2014     DOI:10.1093/annonc/mdu333.14

Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013

Price, T. J. Segelov, E. Burge, M. Haller, D. G. Tebbutt, N. C. Karapetis, C. S. Punt, C. J. Pavlakis, N. Arnold, D. Gibbs, P. Shapiro, J. D.
EXPERT REVIEW OF ANTICANCER THERAPY, 2014     DOI:10.1586/14737140.2014.949678

Assessment of IL-6, IL-8, bFGF, PDGF-BB, and VEGF-A as prognostic and predictive biomarkers for anti-VEGF in metastatic colorectal cancer

Price, T.J. Townsend, A.R Bruhn, M. A. Lee, C. Wrin, J. Shivasami, A. Arentz, G. Tebbutt, N.C. Cunningham, D. Hardingham, J.

Building an implementation science program in lung cancer care: results from Sydney Catalyst translational cancer research centre

Rankin, N. Shaw, T. McGregor, D. Butow, P. White, K. Young, J. Phillips, J. Pearson, S. York, S. Simes, J. Jones, R. Barnes, D. Stone, E.

Final results of Australasian Gastro-Intestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines

Ransom, D. Wilson, K. Fournier, M. Simes, R. J. Gebski, V. Yip, D. Tebbutt, N. Karapetis, C. S. Ferry, D. Gordon, S. Price, T. J.
ANNALS OF ONCOLOGY, 2014     DOI:10.1093/annonc/mdt479

Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary

Reed, N. S. Gomez-Garcia, E. Gallardo-Rincon, D. Barrette, B. Baumann, K. Friedlander, M. Kichenadasse, G. Kim, J. W. Lorusso, D. Mirza, M. R. Ray-Coquard, I.

Dummy run in the phase III LAP07 pancreatic cancer trial: First evaluation of quality of radiation therapy planning

Ricadot, S. Hammel, P Chibaudel, B Goldstein, D. Spry, N Van Laethem, J. Van Houtte, P. Glimelius, B Gubanski, M. Huguet, F

Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial

Ringash, J. Au, H. J. Siu, L. L. Shapiro, J. D. Jonker, D. J. Zalcberg, J. R. Moore, M. J. Strickland, A. Kotb, R. Jeffery, M. Alcindor, T. Ng, S. Salim, M. Sabesan, S. Easaw, J. C. Shannon, J. El-Tahche, F. Walters, I. Tu, D. O'Callaghan, C. J. NCIC Clinical Trials Group, Australasian Gastrointestinal Trials Group,
CANCER, 2014     DOI:10.1002/cncr.28410